Pharmaceutical Strategy for Europe
Adopted on 25 November 2020, the European Commission proposal for Pharmaceutical Strategy for Europe aims at creating a future proof regulatory framework and at supporting industry in promoting research and technologies that actually reach patients in order to fulfil their therapeutic needs while addressing market failures. This ambitious initiative has the potential to modify the general legislative framework for medicinal products in Europe.
We believe it is essential to future proof the legislative framework and continue promoting research and technologies that reach patients, while building on and maintaining a distinct Regulation and Directive.
This dedicated webpage contains our various works on the Pharmaceutical Strategy. Should you wish to know more on this dossier, please contact our colleague Victor Maertens.